Accordingly, glutamine-depriving conditions compromise the growth and proliferation of activated T cells in vitro (79, 80), whereas restoration of tumor interstitial glutamine levels by tumor-specific GLS1 knockout increases T-cell infiltration and activity in vivo (Figure 4B) (38). Here, GLS is linked to neoplasm.